大量和单细胞转录组分析揭示了T细胞介导的瘤杀死在胰腺癌中的分子特征
Yin-Wei Dai1, Ya-Ting Pan2, Dan-Feng Lin1
1Department of Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Heliyon
|March 7, 2024
概括
确定患者子组是胰腺腺癌 (PAAD) 免疫检查点阻塞 (ICB) 成功的关键. 这项研究揭示了PAAD中T细胞介导瘤杀死 (TTK) 的独特模式,有助于个性化免疫疗法策略.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
背景情况:
- 免疫检查点阻塞 (ICB) 对胰腺腺癌 (PAAD) 有希望,但需要对患者进行分层.
- 通过T细胞介导的瘤杀死 (TTK) 是ICB疗效的核心.
- 确定可能受益于ICB的特定PAAD患者亚组至关重要.
研究的目的:
- 根据与TTK敏感性相关的基因探索PAAD亚型.
- 了解TTK相关基因与PAAD免疫治疗反应之间的联系.
- 在PAAD中开发免疫治疗敏感性的预测评分系统.
主要方法:
- 在PAAD中检查了控制T细胞诱导瘤破坏 (GSTTK) 的基因.
- 利用无监督聚类将PAAD样本根据GSTTK划分为两个子集.
- 开发并验证了TRGscore用于预测免疫疗法和化疗反应.
主要成果:
- 确定了两个PAAD集群,具有明显的TTK模式,预后相关性和免疫微环境特征.
- 在群集之间观察到生存,免疫细胞透和免疫治疗反应的显著差异.
- 该TRGscore准确预测了患者对免疫疗法和化疗的反应,以及整体存活率.
结论:
- 在PAAD中,TTK显著影响瘤免疫微环境 (TIME).
- 了解TTK模式的变化可以增强对TIME特征的了解.
- 这项研究提供了对PAADT细胞功能的见解,指导了改进的治疗策略.
相关概念视频
01:27Cytotoxic T Cells-mediated Immune Response
908
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
908
01:27Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524